APU
SGYP

Alpine Partners USVI’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Alpine Partners USVI’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-154,635
Closed -$697K – 44
2013
Q3 		$697K Buy
+154,635
New +$693K 2.61% 10

Other funds holding SGYP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Alpine Partners USVI's SGYP Position: Q4 2013 in Review

Alpine Partners USVI sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2013, closing a stake of 154,635 shares — an estimated $697K sold.

Alpine Partners USVI first reported a position in SGYP in Q3 2013 and held it in 1 quarter. The position peaked at $697K in Q3 2013. 72 funds tracked by Wall St. Rank hold SGYP as of Q4 2013.

  • Alpine Partners USVI reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2013 after selling out during the quarter.
  • Alpine Partners USVI sold 154,635 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2013, an estimated $697K.
  • Alpine Partners USVI first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2013 and held it in 1 quarter.
  • Alpine Partners USVI's Synergy Pharmaceuticals, Inc Common Stock position peaked at $697K in Q3 2013.
  • 72 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2013.

Based on Alpine Partners USVI's 13F filing for Q4 2013, filed 14 Feb 2014.